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Abstract
Multiresistant Enterobacteriaceae, like carbapenemase-producing
strains, have their primary reservoir in medical institutions. They
can also be found with increasing tendency in other reservoirs.
One possible way for entrance of multiresistant Enterobacteria-
ceae into the environment is via waste water. The aim of the study
was to screen isolates from a wastewater treatment plant for the
presence of carbapenemase-producing Enterobacteriaceae. Three
isolates harboured carbapenemase genes, one Klebsiella pneumo-
niae harboured KPC-2 and one K. pneumoniae and one Escherichia
coli harboured OXA-48. This is the ﬁrst report of carbapenem-
ase-harbouring Enterobacteriaceae isolated outside medical insti-
tutions in Austria and the ﬁrst detection of KPC-harbouring
K. pneumonia MLST ST 1245.
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Multiresistant Enterobacteriaceae have become a relevant
problem in human medicine.
In the evolution and spread of multiresistant Enterobacte-
riaceae, carbapenemases are the new threat, overcoming one
of the last lines in antibiotic defence. The classic carbapene-
mases are metallo-b-lactamases (Ambler class B), ﬁrst
detected in the 1990s. Different metallo-b-lactamase gene
families have their hotspots all over the world. The enzyme
KPC is the most recent member in the carbapenemase family,
ﬁrst detected in Turkey in 2003. It is the clinically most
relevant Ambler class A serin b-lactamase with worldwide
dissemination in the last decade. KPC are mainly present in
Klebsiella spp. but can also be found in other Enterobacteri-
aceae and also occur in other gram-negative bacteria. In
contrast, OXA-48 and its derivatives (Ambler class D) are only
harboured by Enterobacteriaceae [1–3].
In central Europe, carbapenemases are only sporadically
detected but with increasing tendency [3]. This is reﬂected
by Austrian studies that show NDM-1, KPC, VIM, IMP
and OXA-48 in human isolates. Since 2010 a rapid increase
of KPC-producing Enterobacteriaceae has been observed [4–
7].
Multiresistant Enterobacteriaceae with different resistance
mechanisms have their primary reservoir in medical institu-
tions. They can also be found with increasing tendency in the
general public, in companion, farm and wildlife animals and in
environmental samples [8–10]. It seems only a matter of time
until resistance mechanisms ﬁnd their way out of medical
institutions into the human community and the environment.
One possible route for the entrance of multiresistant Entero-
bacteriaceae into the environment and so into the food chain
is via waste water. Several studies demonstrate the presence
and increase of (multi)resistant bacteria in the aquatic
environment caused by human waste water [11–13]. Some
of these studies indicate that carbapenemases will follow these
footsteps and reports have been published of carbapenem-
ase-producing Enterobacteriaceae in the aquatic environment
[14,15]. In Austria, previous studies evaluating waste water or
sewage sludge could not detect carbapenem-resistant Entero-
bacteriaceae [12,16,17].
The aim of the study was to screen activated sewage sludge
from an Austrian wastewater treatment plant for the presence
of carbapenemase-producing Enterobacteriaceae.
In the period between September 2011 and February 2012,
activated sewage sludge samples were collected once a month
from the basin of the incoming untreated waste water at a
sewage treatment plant in the area of Graz, Styria/Austria [16].
Wastewater entry into this treatment plant (max. 500 000
population equivalent) is mainly domestic waste water, but also
includes waste water from a hospital (1533 beds). Samples
were mixed with sterile glycerine (50% glycerine by volume)
and frozen at 80°C.
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For screening, 200 lL of the complete thawed samples was
plated on chromID CARBA (bioMerieux, Craponne, France)
screening agar plates.
For pure cultures, colonies growing on CARBA agar were
transferred to blood agar and Endo agar (24 h, 37°C).
Identiﬁcation was performed using the matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry (MAL-
DI-TOF-MS; AximaTM Assurance Shimadzu, Kyoto, Japan)
system. Identiﬁed Enterobacteriaceae were characterized for
their resistance pattern by susceptibility testing according to
EUCAST 2012 (listed in the supplementary data). The MICs
for three carbapenems were tested (ertapenem, imipenem and
meropenem) with E-test (bioMerieux).
Isolates showing resistance to at least one of the tested
carbapenems were screened with a Checkpoint MDR 103 kit
(Check-Points, Wageningen, The Netherlands) according to
the protocol http://www.check-points.com/support/manuals/.
Sequencing of the detected carbapenemases and of the
members of the extended-spectrum b-lactamase (ESBL) gene
family was performed as previously described [17–19]. All
isolates were also typed by multilocus sequence typing, as
previously described. [20,21].
Altogether nine Enterobacteriaceae could be detected on
the carbapenem screening plates (three Escherichia coli, four
Klebsiella spp., two Enterobacter spp.).
Three isolates—two Klebsiella pneumoniae and one E. coli
—out of three different samples, showed resistance to at least
one of the tested carbapenems. Two OXA-48 genes and one
KPC-2 gene were detected.
Isolate SeS1 was a K. pneumoniae harbouring a KPC-2 gene
and in addition the non-ESBL genes SHV-26 and TEM-1.
Additionally, a FOX gene for AmpC b-lactamase was detected.
Co-resistance was found for ciproﬂoxacin and moxiﬂoxacin.
Multi-locus sequence typing assigned the isolate to a novel
sequence type ST1245. The E. coli isolate (SeS2, ST38) was
harbouring an OXA-48 gene and in addition an ESBL
CTX-M-14 gene and TEM-1 gene. In addition, this isolate
showed resistance for gentamicin and trimethoprim-sulfa-
methoxazole. The third isolate (SeS3, ST15), a K. pneumoniae
harboured the genes OXA-48, CTX-M-15 and non-ESBLs
TEM-1 and SHV-1. Co-resistance was found for gentamicin and
trimethoprim-sulfamethoxazole (Table 1).
Carbapenemase-producing Enterobacteriaceae in the sam-
ples are only represented by isolates expressing serin
b-lactamases. KPC was ﬁrst detected in Austria in 2010 with
a growing number of isolates, including nosocomial out-
breaks. In Europe, KPC is endemic in some countries such as
Italy or Greece [6,22]. There are also some reports of
KPC-producing Enterobacteriaceae from wastewater and
river-water samples from Europe and other parts of the
world [14,23].
OXA-48 seems to be not very common in Austria, but
there are only a few studies and all of them only have local
data settings [4,5,7]. Also, publications from neighbouring
regions suggest that OXA-48 is more common in Austria
than the literature would suggest [6]. Another characteristic,
which may lead to an underestimation of OXA-48 in Austrian
clinical samples, is the reduced carbapenem resistance that
can be observed in OXA-48-harbouring strains [1]. Entero-
bacteriaceae harbouring metallo-b-lactamases have been
known in Austria since 2005 [4] but no positive isolates
were found in this study. It is known from other studies that
metallo-b-lactamase carbapenemase has the ability to spread
into the environment [24]. This may be a reﬂection of a more
dramatic spread of KPC and OXA-48 in the human and
clinical settings, but may be a result of the low number of
samples used.
This is the ﬁrst report of KPC- and OXA-48-producing
Enterobacteriaceae isolated outside medical institutions in
Austria. The presence of these strains in waste water is very
low but this is only a ﬁrst investigation. Further studies have to
be conducted to evaluate the presence of these strains in
other environmental samples, such as river water or animals.
Until now, even in the medical setting there is a lack in
screening and reporting carbapenemase-producing Enterobac-
teriaceae.
These ﬁndings are worrying because they document the
ﬁrst step of these genes out of the clinical setting into the
environment and from there, by using water from river and
sewage sludge for agriculture, back into the human community.
TABLE 1. Carbapenemase-producing Enterobacteriaceae isolated from activated sewage sludge
Isolate no. Species MLST Isolation date
MIC (mg/L)
Carbapene mases Other b-lactamasesETP IMP MEM
SeS1 Klebsiella pneumoniae ST 1245 September 2011 8 4 8 KPC-2 TEM-1, SHV-26, FOX
SeS2 Escherichia coli ST 38 November 2011 4 2 0.5 OXA-48 TEM-1, CTX-M-24
SeS3 Klebsiella pneumoniae ST 15 February 2012 2 2 1 OXA-48 TEM-1, SHV-1, CTX-M-15
ETP, ertapenem; IMP, imipenem, MEM, meropenem; MLST, multilocus sequence typing.
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Supporting Information
Additional Supporting Information may be found in the online
version of this article:
Data S1. Supplemental Methods.
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